Back to Startups

Biostate AI

About Biostate AI

Fusing next-gen RNA sequencing with generative AI to revolutionize molecular medicine.

Business Information
Target Customers
biotech companies pharmaceutical companies research institutions
Industry Categories
Bioscience & Disease AI, ML, Gen AI Deep Tech
Business Model
Revenue Model SaaS
Pricing Strategy Subscription-based with tiered access
Sales Channels direct sales, partnerships with research institutions
Funding Timeline
Round Date Amount Investors
Series A May 21, 2025 $12.0M a16z Crypto Startup Accelerator (CSX), Gaingels, 850 Management +1 more
Founders

No founder information available.

Investors
8
850 Management

Venture Capital

G
Gaingels

Venture Capital

I
InfoEdge

Venture Capital

Recent Mentions
gigabaiofficial
Gigabai.com @gigabaiofficial
May 21, 2025

πŸš€ Big news in biotech! Biostate AI has just raised **$12M** to fuse next-gen RNA sequencing with generative AI. πŸ’‘ This isn’t just a step forward – it’s paving the way for *the ChatGPT of molecular medicine*! πŸ‘©β€πŸ”¬βœ¨ [1/5] Led by Accel, this Series A round also saw support from

Palak_Chahal1
Palak Chahal @Palak_Chahal1
May 26, 2025

Biostate AI, a deeptech startup working at the intersection of artificial intelligence and RNA sequencing, has raised $12 million in a Series A funding round led by venture capital firm Accel, with https://t.co/uoWqkXQlyp participation from Gaingels, Mana Ventures, InfoEdge